Company news: Amgen (AMGN) quarterly earnings beat analysts’ forecast

Amgen (AMGN) reported Q3 FY 2021 earnings of $4.67 per share (versus $4.37 per share in Q3 FY 2020), beating analysts’ consensus estimate of $4.22 per share.

The company’s quarterly revenues amounted to $6.706 bln (+4.4% y/y), roughly in line with analysts’ consensus estimate of $6.691 bln.

The company raised FY 2021 EPS guidance to $16.50-17.10 from $16.00-17.00 (versus analysts’ consensus estimate of $16.38), but lowered FY 2021 revenues guidance to $25.8-26.2 bln from $25.8-26.6 bln (versus analysts’ consensus estimate of $26 bln).

AMGN fell to $211.99 (-1.06%) in pre-market trading.